Quick Answer
Sanara MedTech Inc. reported Long-Term Debt of $45.97 million for fiscal year 2025.
Sanara MedTech Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $45.97M | +49.8% |
| 2024 | $30.69M | +236.8% |
| 2023 | $9.11M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.09M | +49.9% | +2.0% |
| June 30, 2025 | $44.22M | +207.7% | +1.9% |
| March 31, 2025 | $43.40M | +395.0% | +41.4% |
| December 31, 2024 | $30.69M | +236.8% | +2.0% |
| September 30, 2024 | $30.08M | +218.0% | +109.3% |
| June 30, 2024 | $14.37M | — | +63.9% |
| March 31, 2024 | $8.77M | — | -3.8% |
| December 31, 2023 | $9.11M | — | -3.6% |
- Sanara MedTech Inc. showed an increase of +49.8% in Long-Term Debt compared to the prior fiscal year.
- Over the 2023–2025 period, Sanara MedTech Inc.’s long-term debt has grown by 404.4% (from $9.11 million to $45.97 million).
- The most recent figure is from Sanara MedTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: